ALSPW Spineway SAS

Extraordinary General Meeting's minute

Extraordinary General Meeting's minute

Press release        Ecully, November 13, 2023 – 6.00 p.m.



Minutes of the General Meeting of November 10, 2023

An Extraordinary General Meeting of Spineway shareholders was held on first notice on Friday, November 10, 2023 at 9:30 a.m. at the company’s registered office, 7 allée Moulin Berger in Ecully (69).

Taking into account the representation of defaulting shareholders by SELARL TULIER POLGE ALIREZAI, as ad hoc agent appointed by Order of the President of the Commercial Court of Lyon dated October 30, 2023, the number of shares held by the shareholders present and represented was 31,898,246 shares and 31,893,331 voting rights. As a quorum was reached, the Meeting was able to be held and make decisions normally.

All resolutions submitted to the Extraordinary General Meeting were adopted, including the first resolution concerning the capital reduction, motivated by losses, in a nominal amount of €1,531,115.81 through a reduction in the par value of each share from €0.05 to €0.002.

As a result, the Company’s share capital has been reduced from €1,594,912.30 to €63,796.49, divided into 31,898,245 shares with a par value of €0.002 each.

Information relating to the Extraordinary General Meeting of 10 November 2023 is available on the Company’s website under “Investors/Regulated Information”: .

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.

Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).

ISIN: FR001400BVK2 - ALSPW        

Contacts:

SPINEWAY



Shareholder-services line

Available Tuesday through Thursday

+33 (0)806 706 060
ELIGIBLE PEA / PME





ALSPW



Euronext Growth

AELIUM



Finance & Communication



Investor relations

Solène Kennis

Attachment



EN
13/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

SPINEWAY : Minutes of the General Meeting of April 2, 2026

SPINEWAY : Minutes of the General Meeting of April 2, 2026 Ecully, April 7, 2026 – 8:00 a.m. SPINEWAY Minutes of the General Meeting of April 2, 2026 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Thursday 2 April 2026 at 10.00 am at the company’s registered office, 7 allée Moulin Berger in Ecully (69). The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated February 24, 2026. The number of shares held by s...

 PRESS RELEASE

SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026

SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026 Ecully, le 7 avril 2026 – 8h00 SPINEWAY Compte-rendu de l’Assemblée Générale du 2 avril 2026 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur première convocation ce jeudi 2 avril 2026 à 10 heures au siège social de la société, 7 allée Moulin Berger à Ecully (69). Les actionnaires défaillants ont été représentés par la SELARL TULIER POLGE ALIREZAI, en qualité de mandataire ad hoc nommé par Ordonnance du Président du Tribunal de commerce de Lyon en date du 24 février 20...

 PRESS RELEASE

Spineway : 2025 annual results

Spineway : 2025 annual results Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands of euros Revenue12,43011,950 11,950Cost of sales-3,783-3,699 -3,699Gross margin 8,6478,250 8,250% of revenue69,6%69,0% 69%Net operating expenses-10,780-10,227 -9,131Of which external expenses-3,967-3,522 -3,646Of which personnel expenses-4,600-4,890 -4,890     Of which other op. income and expenses-1,436-920 -358Of which dep., amort., and provisions-777-895 ...

 PRESS RELEASE

SPINEWAY : Résultats annuels 2025

SPINEWAY : Résultats annuels 2025 Ecully, le 17 février 2026 – 18h30 SPINEWAY Résultats annuels 2025 Un chiffre d’affaires en progression de + 4%Une amélioration des résultatsUn potentiel de croissance renforcé Compte de résultat consolidé résumé20252024Proforma* 2024PubliéEn milliers d'euros Chiffre d'affaires12 43011 950 11 950Coût des ventes-3 783-3 699 -3 699Marge brute8 6478 250 8 250% du CA69,6%69,0% 69%Coûts nets d’exploitation-10 780-10 227 -9 131Dont charges externes-3 967-3 522 -3 646Dont charges de personnel-4 600-4 890 -4 890     Dont autres pdts et ch. d'exploitation-1 43...

 PRESS RELEASE

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sal...

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sales in Q4 2025 (+34%) Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2 revenue6,8575,415+27%Full-year revenue12,43011,950+4% Unaudited consolidated data In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, benefited from an acceleration in sales across all of its markets and the receipt of key account orders d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch